The Oklahoma Medical Research Foundation is one step closer to beating rare forms of brain cancers.
The drug treats fast-growing, deadly brain cancers with no effective treatment.
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.
As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
Agreement will expand clinical trials of glioblastoma drug